CEVA in Italy acquires DIMAF
08 July 2010 - 11:39 CET
Deal marks CEVA's entry into the Italian pharmaceutical marketMilan, Italy, 8 July 2010 - CEVA Logistics, a leading global supply chain management company, today announced its entry into the pharmaceutical market in Italy following the acquisition of DIMAF Pharma Supply Chain, a pharmaceutical supply chain specialist company which has been active in this sector for more than 30 years.
DIMAF is among the top five in pharmaceutical logistics in Italy and is historically positioned for its ability to deliver a service of excellence, recognized by the market, strongly oriented to the needs and characteristics of each customer. DIMAF manages the supply chains of around 30 pharmaceutical companies, including several multi-nationals.
In 2009, DIMAF reported a turnover of €15 million and has around 90 direct employees; the company is present throughout Italy with three temperature controlled warehouses in the Lombardy and Lazio regions, with a total area of 35,000 sq m. DIMAF offers also services of "Officina Farmaceutica": areas that meet specific standards in terms of sanitary regulations and "good manufacturing practices", with highly experienced personnel dedicated to value added services.
Through the introduction of innovative services, CEVA plans to increase the value for the customers; an approach which has already been proven to work in other sectors where CEVA operates.
Gianfranco Sgro, President of CEVA for Southern Europe, Middle East and Africa, said: "The pharmaceutical sector is an interesting area for us. This latest acquisition will allow us to offer the market the best practice in logistics and know-how which have led to CEVA being recognized as leader in many of the sectors in which we operate. In addition, the experience which CEVA has gained internationally in this market sector will be leveraged to allow us to offer innovative and technically advanced services, which are capable of optimizing delicate and complex supply chains such as those characterized by the pharmaceutical market."
For more information contact:
Danilo Schipani
Marketing & Communication Director, SEMEA
+39 02 8923 0354
danilo.schipani@cevalogistics.com
Operation is under approval by the Antitrust Authority.
CEVA - Making Business Flow
CEVA Logistics provides world class supply chain solutions for large and medium-size national and multinational companies across the globe. As an industry leader, CEVA offers customers complete supply chain design and implementation in contract logistics and freight management, alone or in combination. CEVA's integrated global network has facilities in over 170 countries and more than 46,000 employees; all dedicated to delivering consistently excellent operations and supply chain solutions. For the year ending 31 December 2009, the Group reported revenues of €5.5 billion. For more information, please visit, please visit www.cevalogistics.com.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT of 1995:
The statements included in this news release, and other statements that are not historical facts, may contain forward-looking statements. In addition to the assumptions specifically mentioned in the above paragraphs, there are a number of other factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. These factors include, but are not limited to, the process of combining EGL and CEVA, the actual effects of recent and future regulatory changes and technological developments, globalization, levels of spending in major economies, the economic downturn in Asia, Europe and the US, including the economic downturn in the automotive sector, levels of marketing and promotional expenditure, actions of competitors and joint venture partners, employee costs, future exchange and interest rates, changes in tax rates, unexpected costs of future business combinations or dispositions and other factors detailed in risk factors and elsewhere in CEVA most recent Annual Reports. Further information concerning the Company and its business, including factors that potentially could materially affect the Company's financial results, is contained in the Company's annual and quarterly reports, available on the Company's website. Should one or more of these risks or uncertainties materialize or the consequences of such a development worsen, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. CEVA disclaims any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.
